You can save this article by registering for free here. Or sign-in if you have an account. It has the form and texture of a classic crime novel, its antecedents stretching back decades to the ...
Decided to add this retail giant to your portfolio? Here's what you need to know before buying Amazon stock. Many, or all, of the products featured on this page are from our advertising partners ...
You’re reading a free article with opinions that may differ ... and more. Learn More *Stock prices used were the market prices of January 17, 2025. The video was published on January 17, 2025.
The Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 drugs under Medicare Part D, including Novo Nordisk's (NVO) blockbuster GLP-1s.
Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.
(AP Photo/Evan Vucci) · ASSOCIATED PRESS It is unclear if the incoming Trump administration will honor this list and the process or change it after taking office on Jan. 20. Outgoing Health and Human ...
which is considered a key part of the long-term global manufacturing strategy for the drug. While the CRL has led to a significant drop in Atara's stock, the company's proactive approach to ...